可治疗的特征引导喘管理:可行性研究
James Fingleton1, Rob McLachlan1,2, Jenny Sparks2
1Te Whatu Ora - Capital, Coast and Hutt Valley, Wellington, New Zealand.
概括
对喘的个性化药物是可行的和可以接受的,显示出临床益处. 然而,针对2型炎症等特定特征的治疗对于大多数患者的喘完全控制是不够的.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 个性化药物 个性化药物
背景情况:
- 可治疗的基于特征的个性化药物已在严重喘管理中取得成功.
- 在专门的严重喘诊所之外应用这种方法的可行性尚未得到充分证实.
研究的目的:
- 评估一项随机对照试验 (RCT) 的可行性,用于在没有参加严重喘诊所的患者中进行协议化的可治疗特征导向喘管理.
- 评估招募率,干预的可接受性和愿意参加未来的RCT.
主要方法:
- 一项为期10周的单组队列研究,涉及被诊断患有喘的参与者,不受控制的症状 (ACQ-5得分大于1) 和最近的恶化.
- 基于生物标志物指导的喘药物调整,基于针对2型炎症和气流阻塞的协议.
- 可行性结果包括招募,可接受性,愿意参加RCT,需要扩展特征评估,以及特征流行率估计.
主要成果:
- 招聘在14个月内实现了29/50的参与者,邀请接受率为25%,受到COVID-19的影响.
- 92%的参与者认为干预是可以接受的,并愿意加入未来的RCT.
- 尽管喘控制问卷-5 (ACQ-5) 评分有所改善,气流限制减少,但65%的喘仍然无法控制,需要进行扩展评估. 41%的人需要持续服用口服皮质类固醇.
结论:
- 协议化可治疗性状管理是可以接受的,并提供临床益处,支持完整的RCT的可行性.
- 仅仅针对2型炎症和气流阻塞,就不足以在大多数参与者中实现喘控制.
- 发现了显著的全身皮质类固醇暴露,强调了对综合性喘管理策略的进一步研究的需要.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
304
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
304
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
206
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
206
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K


